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(C) Expression of Id1, Id2, and Id3, normalized to the expression of Rpl19, measured by qPCR on cDNA prepared from primary brainstem glial cells derived from Acvr1 floxG328V/+ pups, transduced with
Ad-GFP or Ad-GFP-Cre, and treated or not with 100 ng/mL follistatin (fst) and/or 100 ng/mL noggin (Nog (G) Model of the cellular effects of the Acvr1 G328V mutation on BMP target gene expression and cell proliferation, inferred from the data shown in this paper. Acvr1 G328V increases the expression of Id1, Id2, and Id3, and drive cell cycle progression in the absence of growth factors through a mechanism involving enhanced E2F-dependent transcriptional activity, likely as a result of increased ID2 levels. Control ASCL1+SOX11 Normalized expression of ASCL1 and SOX11 in normal brain tissue and ACVR1-WT or ACVR1-Mut DIPG tumor samples. Each row represents an individual patient. Normal brain: n=17; ACVR1-WT: n=29; ACVR1-Mut: n=5. (F) Luminescent reporter activity in lysates from C2C12 cells transfected with the BRE-Luc reporter and constructs encoding wild-type (WT) or R206H mutant ACVR1, and exposed to 50 ng/mL BMP6 and the indicated concentrations of E6201 overnight. Data are shown as fold over luminescence activity in untreated cells transfected with wild-type (WT) or R206H mutant ACVR1. n= 3 experiments.
(G) Chemical structure of E6201.
(H) 2Fo-Fc electron density map for E6201 in the ACVR1 complex contoured at 1 σ.
(I) Superposition of the E6201 complexes of ACVR1 (brown ACVR1 ribbon, pink E6201) and MEK1
(grey MEK1 ribbon, green E6201; PDB 5HZE). MEK1 shows covalent binding to E6201 through Cys207, which is replaced by Ala353 in ACVR1.
(J) MEK1 complex shows an αC out, DFG-out conformation in contrast to the αC in, DFG-in conformation of ACVR1. Parts of strands β1 and β2 are omitted for clarity.
(K) Superposition of the ACVR1-E6201 structure (red) with that of the BMPR1B-LDN-193189 inhibitor complex (blue, PDB 3MDY). ACVR1 and BMPR1B adopt distinct inactive conformations of the kinase domain. The BMPR1B structure suggests it favours a more collapsed conformation of the P-loop (β1-β2) that would clash with E6201 (purple dashed line). While no structure exists for the kinase domain of BMPR1A, it is likely to resemble BMPR1B with which it shares 85% sequence identity compared to just 64% for ACVR1. In all panels, *:p<0.05; **:p<0.01; ***:p<0.001, assessed by repeated-measures ANOVA with Tukey multiple comparisons tests. 
